about
Sequential application of ligand and structure based modeling approaches to index chemicals for their hH4R antagonismNeuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ(1-42)-induced toxicity.Identification of essential residues for binding and activation in the human 5-HT7(a) serotonin receptor by molecular modeling and site-directed mutagenesisThe cell cycle molecules behind neurodegeneration in Alzheimer's disease: perspectives for drug development.How to Choose the Suitable Template for Homology Modelling of GPCRs: 5-HT7 Receptor as a Test Case.Lipophilic conjugates of methotrexate with short-chain alkylamino acids as DHFR inhibitors. Synthesis, biological evaluation, and molecular modeling.How does binding of imidazole-based inhibitors to heme oxygenase-1 influence their conformation? Insights combining crystal structures and molecular modelling.Heme oxygenase-2/adiponectin protein-protein interaction in metabolic syndrome.Theoretical calculations of the catalytic triad in short-chain alcohol dehydrogenases/reductases.Potential immunoregulatory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach.TCP-FA4: a derivative of tranylcypromine showing improved blood-brain permeability.Design, synthesis and binding properties of novel and selective 5-HT3 and 5-HT4 receptor ligands.Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 and RL100.4-Methyl-2-[N-(3,4-methylenedioxybenzylidene)hydrazino]thiazole and its reduction product, 4-methyl-2-[N-(3,4-methylenedioxybenzylidene)hydrazono]-4,5-dihydrothiazole.Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin.Evaluation of imidazole-based compounds as heme oxygenase-1 inhibitors.Combining NMR and molecular modelling in a drug delivery context: investigation of the multi-mode inclusion of a new NPY-5 antagonist bromobenzenesulfonamide into beta-cyclodextrin.Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids. I. Synthesis and biological evaluation of lipophilic conjugates of tranylcypromine.Molecular properties of ibuprofen and its solid dispersions with Eudragit RL100 studied by solid-state nuclear magnetic resonance.Combined NMR-crystallographic and modelling investigation of the inclusion of molsidomine into alpha-, beta- and gamma-cyclodextrins.Design, synthesis and binding properties of novel and selective 5-HT(3) and 5-HT(4) receptor ligands.Hydrophobic molecular similarity from MST fractional contributions to the octanol/water partition coefficient.Synthesis, benzodiazepine receptor binding and molecular modelling of isochromeno[4,3-c]pyrazol-5(1H)-one derivatives.Emerging antifungal azoles and effects on Magnaporthe grisea.Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity.Sulfonilamidothiopyrimidone and thiopyrimidone derivatives as selective COX-2 inhibitors: Synthesis, biological evaluation, and docking studiesComputational Comparison of Imidazoline Association with the I2 Binding Site in Human Monoamine OxidasesCorrection to Computational Comparison of Imidazoline Association with the I2 Binding Site in Human Monoamine OxidasesPotential of aryl–urea–benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's diseaseSpectroscopic Investigation and Molecular Modeling on Porphyrin/PAMAM Supramolecular AdductBuilding a model of interaction at the NK-2 receptors: Polycondensed heterocycles containing the pyrimidoindole skeletonUnforeseen alkylating effect of triethylorthoformate in the synthesis of pyrazolotriazolopyrimidine derivativeNovel Benzo[b]thiophene Derivatives as New Potential Antidepressants with Rapid Onset of Action3D-QSAR using 'multiconformer' alignment: the use of HASL in the analysis of 5-HT1A thienopyrimidinone ligandsInteractions of imidazoline ligands with the active site of purified monoamine oxidase ASubstrate and inhibitor specificity of class 1 and class 2 histone deacetylases
P50
Q28543874-5959D7CE-C8F5-404F-9276-4B45E965C7E6Q34671526-4F9203B7-9B68-430A-B746-31772F206BA1Q35584956-18C8A9CB-2CA7-448F-B1D4-F44CECE114A8Q37294277-B860ED2F-596E-4326-80F1-E0669BA2F0CCQ39469192-CA39D8C1-95D6-4203-ADB7-1C71976243E3Q40556150-17AC4080-9404-4883-9087-CA9487A7ED41Q40699263-3840254A-2589-4769-90EF-385020E1DE7FQ41361078-C6A4A7CC-1F3B-4B5A-AB6E-C4EFE884E0A4Q42971962-572C0D15-DC8C-4679-97F8-60C208782DCFQ43251300-003BD479-359E-4297-856B-7218A52776EAQ43292449-2C780629-1B47-4C71-B75A-21FD8236FA8CQ43597602-F4E952AE-E686-4011-BDB9-19F19BAFF971Q43597649-05511DFD-9A5C-41E8-9173-005DE86E7382Q43877048-1F1FA11B-784C-452E-979B-32754D08C7F9Q44126155-E6A88E76-4906-459C-8B55-C187696FDF09Q44203203-4FE37EDA-352E-4363-B82A-41C3D627AB12Q44432670-22550506-A3CD-460D-8586-B0B1481DAD3BQ44728426-E72C9389-D653-4B5D-BD19-3C4533425F57Q46673275-BAD5B330-5109-4C49-895C-B91CA8052D8EQ46678401-532C4D2B-F649-4E68-8593-4F921593C4AAQ46708706-66F27083-2263-418A-9735-F9C2FB20B32CQ46710844-A8AF8480-4144-4A81-AEA2-F353584CC117Q46758100-53CB4613-B68E-4AC2-BBB1-C5972778DFD8Q48440543-D620C276-4A73-41B5-99AE-80E9D027DD51Q51182381-7308FDDC-49E8-49BC-ABD4-03CD96B4708DQ52905856-DB9393D5-8372-4EC6-B11A-E62871A267BAQ57079970-2D28495F-A969-4AFD-8675-54534F243A23Q57956870-8141FC5B-8471-418E-90D9-3F2785DB20C2Q57956875-C7FA9247-936A-4F90-9AAC-E876454BD1CEQ58012851-196999B7-C11E-429A-B20B-E6CE723E12DEQ58234651-126D9AC5-C87F-451A-9CC2-6E1F305C1FAEQ58234708-3014F49C-0208-4B33-9624-FE427ACCCB48Q58234728-EB6992C7-C6A0-463D-8354-2C1D4D2A59D3Q59244532-7F5A5BC7-E3A6-4CE7-AE15-CC0CD250A562Q73013885-A0B11BFE-4059-4E4E-8300-49ACF1993267Q80268305-CEC83081-7A47-4DD0-8734-ED5E9D49FF73Q82981639-64B5AFE5-5C38-47CF-B8C2-B923D3A1FBE4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Salvatore Guccione
@ast
Salvatore Guccione
@en
Salvatore Guccione
@es
Salvatore Guccione
@nl
Salvatore Guccione
@sl
type
label
Salvatore Guccione
@ast
Salvatore Guccione
@en
Salvatore Guccione
@es
Salvatore Guccione
@nl
Salvatore Guccione
@sl
prefLabel
Salvatore Guccione
@ast
Salvatore Guccione
@en
Salvatore Guccione
@es
Salvatore Guccione
@nl
Salvatore Guccione
@sl
P106
P1153
7005255136
P21
P31
P496
0000-0001-9858-7732